David Patience - Chief Financial Officer at TriSalus Life Sciences, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
TLSI, TLSIW on Nasdaq
All Insider Reports
All Insider Reports

David Patience - trading volume in the past year for TriSalus Life Sciences, Inc.

Holdings reported by David Patience for TriSalus Life Sciences, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 268,657 $1,101,493 $4.10 23 Feb 2026 Direct
Employee Stock Option (right to buy) 668,899 24 Nov 2025 Direct Common Stock

Transactions reported by David Patience for TriSalus Life Sciences, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.